- NORTH AMERICA EDITIONAustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Applied DNA Signs Master Services Agreement with Schreiner Group
Applied DNA Sciences (NASDAQ:APDN) has announced it has signed a Master Services Agreement with Schreiner Group in Germany. As quoted in the press release: Applied DNA will supply its SigNature® DNA forensic molecular tag with Beacon® screening feature for Schreiner MediPharm’s high-end security label portfolio within the Pharmaceutical Industry for product and brand protection of its customers’ …
Applied DNA Sciences (NASDAQ:APDN) has announced it has signed a Master Services Agreement with Schreiner Group in Germany.
As quoted in the press release:
Applied DNA will supply its SigNature® DNA forensic molecular tag with Beacon® screening feature for Schreiner MediPharm’s high-end security label portfolio within the Pharmaceutical Industry for product and brand protection of its customers’ supply chains. Schreiner MediPharm will also provide authentication services to its customers using the Applied DNA SigNify® portable DNA readers now in use at the Schreiner ProSecure competence center, providing security technologies and services to Schreiner MediPharm as well as Schreiner Group’s other business units.
In a joint development, SigNature DNA and Beacon were integrated in Schreiner MediPharm’s security label concepts and processes. These were validated over the last 18 months during which time the labels have undergone exhaustive environmental and reliability testing by both partners.
Dr. James Hayward, President and CEO of Applied DNA, said, “Schreiner MediPharm is an industry leader who brings top notch science and engineering to its pharmaceutical label portfolio with a spirit of innovation. Given the reported and continued high incidence rate of counterfeits within the pharmaceutical supply chain, we firmly believe the forensic SigNature DNA-protected labels will be of significant value in ensuring authentic medicines reach patients.”
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.